Price of PCVX with the Market Cap of SYRE

If Vaxcyte, Inc. (PCVX) had the market cap of Spyre Therapeutics, Inc. (SYRE), one PCVX would cost $63.92, 5.35% less than today's price of $67.53. The market cap of Vaxcyte, Inc. ($10.63B) is 1.06 times that of Spyre Therapeutics, Inc. ($10.06B).

Result

With The Market Cap of

$63.92
(0.95x)

PCVX is 1.06x above SYRE

PCVX.US Market Cap
PCVX.US M. Cap:
$10,628,524,010
SYRE.US Market Cap
SYRE.US M. Cap:
$10,059,762,600
Wonder your profit?
Estimated value:
$0.00
PCVX
PCVX is 1.06x above SYRE
PCVX.US Market Cap
PCVX.US M. Cap:
$10,628,524,010
SYRE.US Market Cap
SYRE.US M. Cap:
$10,059,762,600

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Vaxcyte, Inc. vs Spyre Therapeutics, Inc.: key figures

Vaxcyte, Inc. PCVX Spyre Therapeutics, Inc. SYRE
Rank #1939 #2017
Price $67.53 $109.00
Market cap $10.63B $10.06B
Shares Outstanding 157.39M 92.29M
Change (1 day) +5.70% +4.95%
Change (1 year) +48.25% +381.66%

The other way round: SYRE with the market cap of PCVX

$115.16 (1.06x)

If Spyre Therapeutics, Inc. (SYRE) had the market cap of Vaxcyte, Inc. (PCVX), one SYRE would cost $115.16, 1.06 times today's price of $109.00.

Price of SYRE with the Market Cap of PCVX

Price of PCVX with the Market Cap of SYRE: the last 12 months

The price of one PCVX if Vaxcyte, Inc. had the market cap of Spyre Therapeutics, Inc., at the end of each month. Highest: $220.22 (Jun 2026). Lowest: $17.59 (Jan 2026).

  1. $18.02 Dec 2025
  2. $17.59 Jan 2026
  3. $109.36 Feb 2026
  4. $128.26 Mar 2026
  5. $189.31 Apr 2026
  6. $182.32 May 2026
  7. $220.22 Jun 2026
  8. $59.22 Jul 2026
  9. $53.72 Aug 2026
  10. $53.54 Sep 2026
  11. $56.62 Oct 2026
  12. $63.92 Nov 2026

Questions about Vaxcyte, Inc. and Spyre Therapeutics, Inc.

What would the price of Vaxcyte, Inc. be with the market cap of Spyre Therapeutics, Inc.?

If Vaxcyte, Inc. (PCVX) had the market cap of Spyre Therapeutics, Inc. (SYRE), one PCVX would cost $63.92, 5.35% less than today's price of $67.53.

How much bigger is Vaxcyte, Inc. than Spyre Therapeutics, Inc.?

The market cap of Vaxcyte, Inc. ($10.63B) is 1.06 times that of Spyre Therapeutics, Inc. ($10.06B). In Dec 2025 the gap was 2.56 times.

What would the price of Spyre Therapeutics, Inc. be with the market cap of Vaxcyte, Inc.?

If Spyre Therapeutics, Inc. (SYRE) had the market cap of Vaxcyte, Inc. (PCVX), one SYRE would cost $115.16, 1.06 times today's price of $109.00.

How is this price calculated?

The market cap of Spyre Therapeutics, Inc. ($10.06B) is divided by the number of PCVX in circulation (157.39M). Market cap is the price multiplied by the number of coins or shares in circulation.